TPO and hematocrit: Currently, the diagnosis of HT relies on thyroglobulin (TgAb) and thyroid peroxidase antibody (TPOAb) detection, yet approximately 20% of HT patients are antibody-negative, resulting in a significant underdiagnosis risk (3).